Our lab's paper on genome-wide in vivo CRISPR screens in human T cells in tumor-bearing mice is out in @Nature, led by @QiLiu_O! The screens identify genetic modifications that improve T cell therapy against solid tumors.
https://t.co/1gYEw0lMYQ
🧵https://t.co/OLbxAUzq1O
Incredibly excited to share the first major paper from my lab @carnevale_lab led by postdoc Qi Liu @GladstoneInst@UCSF executing the first ever genome-wide in vivo screens for genetic modifications to enhance human T cell therapies for solid tumors. Now in @Nature: https://t.co/y8eH3Ek9lK
Incredibly excited to share the first major paper from my lab @carnevale_lab led by postdoc Qi Liu @GladstoneInst@UCSF executing the first ever genome-wide in vivo screens for genetic modifications to enhance human T cell therapies for solid tumors. Now in @Nature: https://t.co/y8eH3Ek9lK
In a new @Nature paper, Dr. Julie Carnevale (@jccarnevale) and her colleagues from @GladstoneInst discovered that turning off a gene in T cells could make them more resilient in #immunotherapy treatments. 🔬
https://t.co/qp48sD5UmW
@carnevale_lab
Very excited to share that our work was published in @Nature today! RASA2 ablation in T cells boosts antigen sensitivity and long-term function https://t.co/q6SC7php89